Semax
Availability Not yet prescribable · sold for research use only
What it is
Semax is a synthetic heptapeptide built from the ACTH(4-10) fragment with a stabilising tail, so it acts on the brain without the hormonal effects of ACTH itself. Developed in Moscow in the 1980s, it is registered in Russia for cerebrovascular and cognitive indications and given as a nasal solution. Nowhere else has approved it.
Why people take it
The pitch is a cognitive peptide with an actual clinical file rather than a bodybuilding forum origin story. People reach for it wanting sharper focus under load, faster recovery after a concussion or a stroke, or relief from brain fog that no scan explains, and the neurotrophin story, higher BDNF and related growth signals, makes the mechanism feel legible.
How it's delivered
Intranasal drops or spray, sometimes injection, on a clinic-set schedule. In the US it has no approved product. FDA placed semax in the safety-risk category for compounding in September 2023, and the nomination was later withdrawn. On October 28, 2026, HHS posted a draft interim policy, open for public comment until mid-November, saying it does not intend to act against licensed pharmacies and physicians that compound semax (free base) for an individual patient's prescription under conditions that include: a single-ingredient nasal product made from a tested ingredient from an FDA-registered facility. That is enforcement discretion, not approval, and HHS can withdraw it. FDA's drug reviewers had recommended against listing semax; its Pharmacy Compounding Advisory Committee voted in favor in July 2026, as HHS's October 2026 policy records. Injected semax is outside it.
Where the evidence stands
Almost the entire human record is Russian, published in Russian-language neurology journals, and centred on acute ischemic stroke rather than healthy cognition. Those studies report better neurological recovery when semax is added to standard care, and mechanistic work shows it raising neurotrophin and receptor gene transcription after cerebral ischemia. Independent Western replication does not exist, trial reporting quality is well below modern standards, and no controlled study supports the everyday nootropic use that drives most demand.
Estimated cost
- No approved product and no verified reference price
- Not covered by insurance
Who offers it
We don't list providers for semax. There is no approved product, and we haven't verified any provider against the conditions of HHS's draft October 2026 interim compounding policy. Anything sold online as a research chemical is outside that policy.
Go deeper
No cognitive peptides guide yet. The Peptide Explorer entry carries the compound record, and the peptide therapy hub explains how to sort an approved drug from a compounded one from a research chemical.
Semax in the Peptide Explorer · Peptide Therapy for Longevity
Longevity.io is for educational purposes only and is not medical advice. Whether a cognitive peptide belongs in a plan is a conversation for a clinician who knows the whole picture, current medications included. Confirm eligibility, product source, and pricing directly with any provider.
Build your starting plan.
A few short questions, about two minutes. The Blueprint recommends where to start and explains why.
Build my Blueprint
